1. Germany Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Bayer AG

Bayer AG

BAYRY
Bayer AGUS flagOther OTC
13.85
USD
-NaN
- -
54.43BMarket Cap

Total Valuation

Bayer AG carries a market capitalization of 54.43B, placing it among publicly traded companies globally. Its enterprise value stands at 6.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap54.43B
Enterprise Value6.82B

Share Statistics

Bayer AG currently has 982.42M shares outstanding.

Shares Outstanding982.42M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.04, and the price-to-book ratio stands at 0.40.

PE RatioN/A
PS Ratio1.04
PB Ratio0.40
P/TBV Ratio-0.60
P/FCF Ratio6.29
P/OCF Ratio9.85

Enterprise Valuation

On an enterprise value basis, Bayer AG trades at an EV/EBITDA multiple of 0.84 and an EV/FCF ratio of 0.65. The EV/Sales ratio of 0.15 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 0.84 provides insight into valuation relative to core operating earnings.

EV / Sales0.15
EV / EBITDA0.84
EV / EBIT0.84
EV / FCF0.65

Financial Position

Bayer AG maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

Current Ratio1.04
Quick Ratio0.16
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage3.89

Financial Efficiency

Return on Equity (ROE)-5.80
Return on Assets (ROA)-1.64
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)11.19
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.54

Taxes

Over the trailing twelve months, Bayer AG has paid 490.00M in income taxes, reflecting an effective tax rate of 36.09.

Income Tax490.00M
Effective Tax Rate36.09

Stock Price Statistics

Bayer AG's stock has gained approximately 79.40415% over the past 52 weeks. The 50-day moving average sits at 12.85, while the 200-day moving average is 11.43.

Beta (5Y)N/A
52-Week Price Change79.40415%
50-Day Moving Average12.85
200-Day Moving Average11.43
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Bayer AG generated 45.38B in revenue and converted that into -1.74B in net income, yielding earnings per share of -0.44. EBITDA reached 8.16B, while operating income came in at 8.16B.

Revenue45.38B
Gross Profit26.80B
Operating Income8.16B
Pretax Income-1.22B
Net Income-1.74B
EBITDA8.16B
EBIT8.16B
Earnings Per Share (EPS)-0.44

Balance Sheet

Total book value stands at 29.58B, with working capital of 1.37B providing operational flexibility.

Cash & Cash Equivalents5.08B
Total DebtN/A
Net Debt-4.29B
Equity (Book Value)29.58B
Book Value Per Share30.11
Working Capital1.37B

Cash Flow

Bayer AG produced 4.78B in operating cash flow over the past twelve months. After subtracting -2.70B in capital expenditures, free cash flow totaled 2.08B - equivalent to 0.53 per share.

Operating Cash Flow4.78B
Capital Expenditures-2.70B
Free Cash Flow2.08B
FCF Per Share0.53

Margins

Bayer AG operates with a gross margin of 59.05, reflecting its pricing power and cost economics. The operating margin of 17.98 and net profit margin of -3.83 provide insight into operational efficiency.

Gross Margin59.05
Operating Margin17.98
Pretax Margin-2.70
Profit Margin-3.83
EBITDA Margin17.98

Dividends & Yields

The company's payout ratio of -7.76 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.03
Dividend YieldN/A
Payout Ratio-7.76
Shareholder Yield26.40
FCF Yield15.89

Stock Splits

Bayer AG's most recent stock split took place on June 6, 2018 with a 200:203 split ratio.

Last Split Date6/6/2018
Split Ratio200:203

Scores

Bayer AG posts an Altman Z-Score of 1.37, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.37